Study shows aspirin is fighting more than pain

More than 100.000 people participated in a study done by Harvard University

(CNN) – Aspirin can be an effective pain reliever, but new research has found another potentially life-saving use for the drug. According to new research from Harvard University, regular doses of aspirin may reduce the risk of dying from cancer.

Of the more than 100,000 people studied, men who took aspirin regularly had a 15 percent lower cancer mortality risk than those who did not, while women saw a seven percent lower mortality risk. In the study, the largest impact for both sexes was with colorectal cancer.

Researchers also suspect aspirin may significantly reduce the risk of death for men with prostate and lung cancer. For women, regular aspirin may help fend off death from breast cancer. Previous studies also found that aspirin can help patients at risk for heart attack or stroke, but not everyone should take a daily aspirin.

Doctors do not recommend it for anyone at a high risk for ulcers or gastrointestinal bleeding, but researchers say the benefits do outweigh the risks for most people.